Cargando…
Colorectal cancer screening—what does the recent NordICC trial mean for the U.S. population?
The incidence of colorectal cancer (CRC) has declined over time, though it remains a significant cause of morbidity and mortality in the U.S. It has the third highest incidence in incidence among all cancers and is the second leading cause of cancer death in both men and women. Screening reduces the...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10643301/ https://www.ncbi.nlm.nih.gov/pubmed/38021363 http://dx.doi.org/10.21037/tgh-23-20 |